Marburgvirus Infections (Marburg Hemorrhagic Fever) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 60 pages | ID: MC34DD772ECAEN
VPAResearch

Abstracts

Marburgvirus Infections (Marburg Hemorrhagic Fever) Drug pipeline report- 2020 is an annual R&D review of Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline candidates. The report presents the current status of all major Marburgvirus Infections (Marburg Hemorrhagic Fever) therapeutic compounds. Detailed insights into Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline development, current status, companies, drug profiles and Marburgvirus Infections (Marburg Hemorrhagic Fever) preclinical and clinical trials are included.

2020 Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Market Insights
Marburgvirus Infections (Marburg Hemorrhagic Fever) disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Marburgvirus Infections (Marburg Hemorrhagic Fever) therapies, pipeline by phase and others are included.

Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Marburgvirus Infections (Marburg Hemorrhagic Fever) Therapeutic Drug candidates
Both active and inactive Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline drug candidates are included in the report

Marburgvirus Infections (Marburg Hemorrhagic Fever) Clinical Trials and preclinical Studies
Marburgvirus Infections (Marburg Hemorrhagic Fever) In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline market developments
Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline companies in active development
The report analyzes Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline of the below companies-

Bavarian Nordic A/S, BioCryst Pharmaceuticals Inc, Emergent BioSolutions Inc, Emergex Vaccines, Fab’entech SA, Fox Chase Chemical Diversity Center Inc., GeoVax Labs Inc, Greffex Inc, Immunomodulation Inc, Integrated BioTherapeutics Inc, Mapp Biopharmaceutical Inc, NanoViricides Inc, Phoenix Biotechnology Inc, Profectus BioSciences Inc, Rodos BioTarget GmbH

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
15 Companies investing in Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Marburgvirus Infections (Marburg Hemorrhagic Fever) pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. MARBURGVIRUS INFECTIONS (MARBURG HEMORRHAGIC FEVER) PIPELINE MARKET INSIGHTS, 2020

1.1 Marburgvirus Infections (Marburg Hemorrhagic Fever) Disease Overview
1.2 Marburgvirus Infections (Marburg Hemorrhagic Fever) Drug Pipeline Snapshot, 2020
  1.2.1 Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs by Phase
  1.2.2 Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs by Company
  1.2.3 Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs by Mechanism of Action
  1.2.4 Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs by Route of Administration

2. MARBURGVIRUS INFECTIONS (MARBURG HEMORRHAGIC FEVER) COMPANY WISE PIPELINE DETAILS

Bavarian Nordic A/S Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
BioCryst Pharmaceuticals Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Emergent BioSolutions Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Emergex Vaccines Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fab’entech SA Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Fox Chase Chemical Diversity Center Inc. Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
GeoVax Labs Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Greffex Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Immunomodulation Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Integrated BioTherapeutics Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Mapp Biopharmaceutical Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
NanoViricides Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Phoenix Biotechnology Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Profectus BioSciences Inc Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details
Rodos BioTarget GmbH Marburgvirus Infections (Marburg Hemorrhagic Fever) Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. MARBURGVIRUS INFECTIONS (MARBURG HEMORRHAGIC FEVER) DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. MARBURGVIRUS INFECTIONS (MARBURG HEMORRHAGIC FEVER) PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts